Filed with the SEC on · accession 0001493152-26-047287
ERNA filed a 8-K (current report) with the SEC on Oct 15, 2026. Ernexa Therapeutics furnished an investor presentation via an 8-K under Regulation FD Disclosure (Item 7.01). The stock moved +2.8% by the first close after the filing.
Ernexa Therapeutics furnished an investor presentation via an 8-K under Regulation FD Disclosure (Item 7.01). The presentation was made available on the company's website and attached as Exhibit 99.1.
Close before
$2.11
Oct 14, 2026
First close after
+2.84%
$2.17
5 trading days
+0.00%
$2.11
Since filing
-8.53%
$1.93
✦ Ask GOAX AI about this filing — what it means for ERNA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ERNA?
Click hereERNA filed a 8-K (SEC filing). Ernexa Therapeutics furnished an investor presentation via an 8-K under Regulation FD Disclosure (Item 7.01). The presentation was made available on the company's website and attached as Exhibit 99.1.
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
ERNA closed at $2.11 before the filing and $2.17 on Oct 15, 2026 (+2.84%). Five trading days later: $2.11 (+0.00%).
Get alerts when ERNA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days